RecruitingPhase 1NCT02897063

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

The Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure Aim 2 of RDCRN (Rare Diseases Clinical Research Network) Project 2


Sponsor

Vanderbilt University Medical Center

Enrollment

34 participants

Start Date

Sep 1, 2016

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to learn more about the effects of midodrine and droxidopa, two medications used for the treatment of orthostatic hypotension (low blood pressure on standing), on the veins of the abdomen of patients with autonomic failure. The study will be conducted at Vanderbilt University Medical Center, and consists of 2 parts: a screening and 2 testing days. The total length of the study will be about 5 days. About 34 participants will be screened for the study.


Eligibility

Min Age: 40 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study investigates how two blood pressure medications — midodrine and droxidopa — affect blood pooling in the belly area in people with conditions that cause low blood pressure when standing up (a condition called neurogenic orthostatic hypotension). **You may be eligible if...** - You are between 40 and 80 years old - You have been diagnosed with a condition like Multiple System Atrophy, Pure Autonomic Failure, or Parkinson's disease - You experience a significant drop in blood pressure when you stand up (dizziness, lightheadedness) due to a nerve problem - You are able to give informed consent **You may NOT be eligible if...** - You do not have a qualifying nervous system condition - You do not experience blood pressure drops when standing - You are unable to safely participate in the study procedures This research may help improve medications that help patients with these nerve disorders stand and move without fainting. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDroxidopa

Single oral dose 300 mg

DRUGMidodrine

Single oral dose 10 mg

DRUGPlacebo

sugar pill


Locations(1)

Autonomic Dysfunction Center/ Vanderbilt University Medical Center

Nashville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02897063


Related Trials